(Q39494709)

English

Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDHhiCD44⁺ human breast cancer cells

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDHhiCD44⁺ human breast cancer cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Alysha K Croker

1

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

2

object named as

Alison L Allan

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

language of work or name

0 references

publication date

5 August 2011

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Breast Cancer Research and Treatment

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

133

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

75-87

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1692-Y

21 January 2018

Dissemination and growth of cancer cells in metastatic sites

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1692-Y

21 January 2018

Prospective identification of tumorigenic breast cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1692-Y

21 January 2018

Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1692-Y

21 January 2018

Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1692-Y

21 January 2018

High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1692-Y

21 January 2018

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1692-Y

21 January 2018

Treatment options for breast cancer resistant to anthracycline and taxane

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1692-Y

21 January 2018

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1692-Y

21 January 2018

Association of reactive oxygen species levels and radioresistance in cancer stem cells

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1692-Y

21 January 2018

The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1692-Y

21 January 2018

CD44-positive cells are responsible for gemcitabine resistance in pancreatic cancer cells.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1692-Y

21 January 2018

Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1692-Y

21 January 2018

The CD44 receptor interacts with P-glycoprotein to promote cell migration and invasion in cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1692-Y

21 January 2018

Snail and slug mediate radioresistance and chemoresistance by antagonizing p53-mediated apoptosis and acquiring a stem-like phenotype in ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1692-Y

21 January 2018

Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1692-Y

21 January 2018

WNT/beta-catenin mediates radiation resistance of mouse mammary progenitor cells

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1692-Y

21 January 2018

Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1692-Y

21 January 2018

Human aldehyde dehydrogenases: potential pathological, pharmacological, and toxicological impact

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1692-Y

21 January 2018

Modern approaches to treating acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1692-Y

21 January 2018

Retinoic acid down-regulates aldehyde dehydrogenase and increases cytotoxicity of 4-hydroperoxycyclophosphamide and acetaldehyde

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1692-Y

21 January 2018

Retinoid signaling regulates breast cancer stem cell differentiation

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1692-Y

21 January 2018

Cellular resistance to anthracyclines.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1692-Y

21 January 2018

Epithelial-mesenchymal transitions in development and disease

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1692-Y

21 January 2018

Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1692-Y

21 January 2018

Preferential antitumor effect of the Src inhibitor dasatinib associated with a decreased proportion of aldehyde dehydrogenase 1-positive cells in breast cancer cells of the basal B subtype.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1692-Y

21 January 2018

ALDH isozymes downregulation affects cell growth, cell motility and gene expression in lung cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1692-Y

21 January 2018

Heterogeneity of aldehyde dehydrogenase expression in lung cancer cell lines is revealed by Aldefluor flow cytometry-based assay

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1692-Y

21 January 2018

Therapy-related myeloid neoplasms in patients with acute promyelocytic leukemia treated with all-trans-retinoic Acid and anthracycline-based chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1692-Y

21 January 2018

Risk-adapted treatment of acute promyelocytic leukemia with all-trans-retinoic acid and anthracycline monochemotherapy: a multicenter study by the PETHEMA group

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1692-Y

21 January 2018

Design and synthesis of novel derivatives of all-trans retinoic acid demonstrate the combined importance of acid moiety and conjugated double bonds in its binding to PML-RAR-alpha oncogene in acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1692-Y

21 January 2018

All-trans retinoic acid (ATRA)-induced apoptosis is preceded by G1 arrest in human MCF-7 breast cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1692-Y

21 January 2018

Pharmacokinetics and clinical impact of all-trans retinoic acid in metastatic breast cancer: a phase II trial

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1692-Y

21 January 2018

Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy?

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1692-Y

21 January 2018

Identifiers

10.1007/S10549-011-1692-Y

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

release_54fh4wflazdc3cfowi4ke7z4c4

1 reference

https://api.fatcat.wiki/v0/release/54fh4wflazdc3cfowi4ke7z4c4

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39494709&oldid=2202928223"